Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)
Public ClinicalTrials.gov record NCT06931405. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study to Evaluate the Safety, Tolerability, and Clinical Activity of BLU-808, a Wild Type KIT Inhibitor, in Chronic Inducible Urticaria and Chronic Spontaneous Urticaria
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a 2-part, proof-of-concept study to be conducted globally, designed to evaluate the safety, tolerability, clinical activity, pharmacokinetics, and pharmacodynamics of BLU-808, a wild type KIT inhibitor, in participants with CIndU (Part A) or CSU (Part B).
Study identification
- NCT ID
- NCT06931405
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 105 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 28, 2025 (Actual)
- Primary completion
- Dec 31, 2026 (Estimated)
- Completion
- Dec 31, 2026 (Estimated)
- Last update posted
- Jul 22, 2026
2025 – 2026
United States locations
- U.S. sites
- 27
- U.S. states
- 18
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Allervie Clinical Research | Birmingham | Alabama | 35209 | — |
| Acuro Research, Inc. | Little Rock | Arkansas | 72205 | — |
| Modena Allergy & Asthma Clinical Research - La Jolla | La Jolla | California | 92037 | — |
| Allergy & Asthma Associates of Southern California | Laguna Niguel | California | 92677 | — |
| Allergy & Asthma Medical Group and Research Center | San Diego | California | 92123 | — |
| Allergy Affiliates Inc. | Bradenton | Florida | 34208 | — |
| University of South Florida | Tampa | Florida | 33613 | — |
| Treasure Valley Medical Research | Boise | Idaho | 83706 | — |
| Endeavor Health | Northbrook | Illinois | 60062 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46250 | — |
| Southern Indiana Clinical Trials | New Albany | Indiana | 47150 | — |
| The Indiana Clinical Trials Center | Plainfield | Indiana | 46168 | — |
| Equity Medical - Bowling Green | Bowling Green | Kentucky | 42104 | — |
| Johns Hopkins University | Baltimore | Maryland | 21224 | — |
| Institute For Asthma & Allergy | Wheaton | Maryland | 20902 | — |
| Chesapeake Clinical Research | White Marsh | Maryland | 21236 | — |
| Henry Ford Health | Detroit | Michigan | 48202 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| The Clinical Research Center LLC. | St Louis | Missouri | 63141 | — |
| Montana Medical Research, Inc. | Missoula | Montana | 59808 | — |
| Equity Medical (at Cameron Dermatology) - New York | New York | New York | 10023 | — |
| Bernstein Clinical Research Center | Cincinnati | Ohio | 45236 | — |
| Allergy & Clinical Immunology Associates | Pittsburgh | Pennsylvania | 15241 | — |
| National Allergy, Asthma & Urticaria Centers of Charleston | Charleston | South Carolina | 29407 | — |
| Medical University of South Carolina (MUSC) | Charleston | South Carolina | 29425 | — |
| Reveal Research Institute | Dallas | Texas | 75235 | — |
| Austin Institute for Clinical Research | Pflugerville | Texas | 78660 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06931405, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 22, 2026 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06931405 live on ClinicalTrials.gov.